August 6, 2024 — Minneapolis, MN — Delve Health, a leader in decentralized clinical trial solutions, is excited to announce a strategic partnership with Strados Labs, an innovator in respiratory health technology. This collaboration aims to enhance remote patient monitoring capabilities in clinical trials, making research more accessible, accurate, and patient-centric.
Advancing Remote Monitoring Solutions
Delve Health has been at the forefront of decentralized clinical trials, providing innovative solutions that make clinical research more efficient and patient-friendly. By partnering with Strados Labs, known for their expertise in real-world monitoring of cough and lung sounds, Delve Health will integrate Strados Labs’ state-of-the-art technology into their platform. This integration will enable drug developers and clinical trialists to objectively and continuously measure respiratory symptoms such as cough and wheeze, a critical component in many clinical trials which are typically measured by subjective patient questionnaires.
Enhanced Remote Patient Monitoring
Delve Health will provide advanced remote monitoring capabilities to clinical trials with Strados Labs’ RESP® Biosensor and remote monitoring platform. Strados Labs’ FDA-cleared wearable device enables drug developers and clinical trialists to collect real-world respiratory data from trial participants to measure treatment response, including primary and exploratory endpoints. The RESP Biosensor allows for continuous, accurate monitoring of respiratory metrics such as lung sounds, cough frequency, and vitals such as respiratory rate (for investigational use only), providing novel insights into treatment response for clinical trials. Additionally, this integration will make it easier for researchers to utilize the RESP Biosensor alongside other connected health devices, streamlining the data collection process.
Improving Accessibility and Convenience
Traditional, or centralized, clinical trials often require participants to make frequent visits to clinical sites, posing a significant burden and barrier to participation. With Strados Labs’ connected technology, research teams can monitor subjects’ respiratory health from the comfort of their homes, fitting seamlessly into decentralized clinical trials. This not only makes clinical trials more convenient and accessible but also improves participant compliance and data accuracy.
Enhancing Compliance and Automating Engagement
Delve Health’s partnership with Strados Labs helps clinical trial teams improve participant compliance by providing user-friendly, connected devices for remote monitoring. Additionally, Delve Health offers a platform to automate participant engagement, ensuring regular communication, reminders, and support throughout the clinical trial. This automation enhances participant retention and ensures high-quality data collection, making it easier for researchers to manage compliance and retention effectively.
Aligning with FDA Guidelines
The FDA has been advocating for the use of digital health technologies to enhance data accuracy and patient engagement in clinical research. The integration of Strados Labs’ RESP Biosensor technology aligns with these guidelines, ensuring that Delve Health’s decentralized trials meet and exceed regulatory standards. This partnership provides robust, real-time data that adheres to FDA requirements, promoting higher standards in clinical research.
Promoting Equitable Research
Ensuring diversity and inclusion in clinical trials is a major challenge. Many populations are under-represented in clinical research due to logistical and socio-economic barriers. By leveraging Strados Labs’ technology, Delve Health can reach a more diverse participant pool. This approach democratizes access to clinical trials and ensures that research findings are more representative of the entire population.
About Delve Health
Delve Health is a pioneer in decentralized clinical trials, dedicated to making clinical research more efficient, patient-centric, and accessible. Their innovative solutions streamline the clinical trial process, ensuring high-quality data collection and improved patient outcomes.
About Strados Labs
Strados Labs is a leader in respiratory health technology, known for their award-winning RESP® Biosensor and remote monitoring platform. Their technology is designed to provide continuous, real-world monitoring of respiratory health symptoms and metrics, empowering drug developers and clinical trialists with stronger evidence and insight into treatment response.
Wessam Sonbol
Delve Health
+1 952-200-6228
Announcing New Partnership with Delve Health
